Uveitis
📧 Sign up to get email alerts when something new happens for Uveitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: A Clinical Trial of Infliximab for Childhood Uveitis [Phase 4]
A Phase 4 clinical trial update for infliximab in childhood uveitis is reported, with the status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) [Phase 4]
Phase 4 trial update on Acthar Gel for inflammation of the eye's uvea, with terminated status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis [Phase 3]
Phase 3 trial evaluating suprachoroidal CLS-TA injection for non-infectious uveitis has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis [Phase 3]
Phase 3 trial update for suprachoroidal CLS-TA injections in macular edema due to non-infectious uveitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study) [Phase 2]
Phase 2 trial evaluating ustekinumab (Stelara) for active sight-threatening uveitis has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis [Phase 3]
A Phase 3 trial comparing Interferon α2a to Cyclosporine for refractory Behçet's disease uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis [Phase 1, Phase 2]
Clinical trial updates safety and efficacy of suprachoroidal triamcinolone acetonide delivered via microneedle for noninfectious uveitis, co…
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis [Phase 2]
Phase 2 clinical trial evaluating suprachoroidal injection of triamcinolone acetonide for macular edema due to non-infectious uveitis has be…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis [Phase 2, Phase 3]
A clinical trial update on Beta-1,3/1,6-D-Glucan Ganoderma Lucidum for non-infectious and idiopathic uveitis across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Tofacitinib for Inflammatory Eye Disease [Phase 2]
A Phase 2 trial evaluating tofacitinib for inflammatory eye diseases (uveitis and scleritis) with results posted in 2021; current status is …
-
EMA withdrawal · 2021-01-29EMA Withdrawn: Halimatoz (adalimumab) — Sandoz GmbH
The EMA withdrew Halimatoz (adalimumab) supplied by Sandoz GmbH from the market.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Macular Edema Nepafenac vs. Difluprednate Uveitis Trial [Phase 4]
Phase 4 trial comparing nepafenac and difluprednate for uveitis-associated macular edema was terminated.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis [Phase 2]
Phase 2 trial update on safety, tolerability, and efficacy of AEB071 for uveitis shows completed study; regulatory implications pending.
-
CLINICAL_TRIALS withdrawal · 2020-09-29Clinical Trial Update: Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis [Phase 3]
Phase 3 extension study for AIN457 in active non-infectious uveitis was withdrawn.
-
EMA withdrawal · 2020-03-25EMA Withdrawn: Kromeya (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA has withdrawn Kromeya (adalimumab) from Fresenius Kabi Deutschland GmbH, effective 2019, affecting multiple inflammatory diseases.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) [Phase 3]
Phase 3 trial update report on long-term safety of gevokizumab in chronic non-infectious uveitis, with the study terminated.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Simvastatin in Uveitis [Phase 2]
Phase 2 trial updating the use of simvastatin for uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Study of the Effectiveness of Ozurdex for the Control of Uveitis [Phase 4]
Phase 4 study assessing the effectiveness of Ozurdex (dexamethasone implant) for control of uveitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography [NA]
A terminated clinical trial evaluating anterior chamber cell grading using ocular coherence tomography in uveitis. Results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Methotrexate and Mycophenolate Mofetil for UVEITIS [Phase 3]
Phase 3 clinical trial investigating methotrexate and mycophenolate mofetil for uveitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis [Phase 3]
Phase 3 study evaluating long-term safety and efficacy of adalimumab in intermediate-, posterior-, or panuveitis completed with results post…
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Abatacept in the Treatment of Uveitis [Phase 2]
Phase 2 clinical trial evaluating abatacept for the treatment of uveitis has completed. Results were posted in 2019.
-
CLINICAL_TRIALS withdrawal · 2019-02-07Clinical Trial Update: Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema [Phase 4]
A Phase 4 clinical trial comparing posterior subtenon versus intravitreal injection of triamcinolone acetonide for uveitic cystoid macular e…
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial [Phase 3]
Phase 3 trial evaluating periocular and intravitreal corticosteroids for uveitic macular edema has completed and results were posted in 2018…